Recent advances in targeting LRRK2 for Parkinson’s disease treatment

Abstract Parkinson’s disease (PD) is a neurodegenerative disease with severe movement problems. Current treatments mainly focus on symptom management by reducing dopaminergic pathways in the brain. Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approac...

詳細記述

書誌詳細

主要な著者:	Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-07-01
シリーズ:	Journal of Translational Medicine
主題:	Parkinson’s disease LRRK2 Neurodegenerative diseases Autophagy PROTAC Mitochondrial dysfunction
オンライン･アクセス:	https://doi.org/10.1186/s12967-025-06354-0
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!